Advertisement

Topics

Cipla to acquire South African drug developer Mirren

19:00 EDT 12 Jul 2018 | Pharmaceutical Technology

Indian pharmaceutical company Cipla has signed an agreement to fully acquire South Africa-based pharmaceutical manufacturer Mirren for R450m ($33.5m). Cipla...
Read More...

The post Cipla to acquire South African drug developer Mirren appeared first on Pharmaceutical Technology.

Original Article: Cipla to acquire South African drug developer Mirren

NEXT ARTICLE

More From BioPortfolio on "Cipla to acquire South African drug developer Mirren"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...